The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The prognostic performance of PREDICT+ in patients (pts) with HER2-positive (HER2+) early-stage breast cancer (EBC).
 
Elisa Agostinetto
No Relationships to Disclose
 
Lieveke Ameye
No Relationships to Disclose
 
Samuel Martel
Honoraria - Exact Sciences; Knight Therapeutics; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Exact Sciences; Knight Therapeutics; Pfizer; Roche; Taiho Pharmaceutical
 
Philippe Georges Aftimos
Honoraria - Gilead Sciences; Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; G1 Therapeutics; Macrogenics; Novartis; Novartis; Radius Health; Roche; Servier
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Pfizer; Roche Belgium
 
Noam Ponde
Honoraria - AstraZeneca; Lilly; Novartis; Roche/Genentech
Consulting or Advisory Role - Lilly
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Roche/Genentech
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Lilly; Novartis
 
Christian Maurer
Travel, Accommodations, Expenses - Abbvie; Amgen; SERVIER
 
Sarra El-Abed
Employment - argenx (I); Astellas Pharma (I)
Research Funding - Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Yingbo Wang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Maria Lourdes Vicente
No Relationships to Disclose
 
Saranya Chumsri
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; bioTheranostics; Eisai; Immunomedics; Immunomedics; Immunomedics; Novartis; Novartis; Puma Biotechnology; Syndax
Research Funding - Array BioPharma; Merck
 
Judith Bliss
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline/Novartis (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Judith R. Kroep
Consulting or Advisory Role - AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Tesaro (Inst); Vitroscan (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst); Philips Research (Inst)
 
Marco Colleoni
Research Funding - Roche (Inst)
 
Fausto Petrelli
No Relationships to Disclose
 
Lucia Del Mastro
Honoraria - Lilly; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Genomic Health; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - Celgene; Pfizer; Roche
 
Alvaro Moreno-Aspitia
Stock and Other Ownership Interests - Merrimack
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from the development of a xenograft model. Royalties were assigned to go to my institution and not personally
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Camel-IDS; Debiopharm Group; Immunomedics; Immutep; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Pfizer; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - EU Cancer Mission Board; Oncolytics
 
Marianne Paesmans
No Relationships to Disclose
 
Evandro de Azambuja
Honoraria - Roche/Genentech; Seagen; Zodiac Pharma
Consulting or Advisory Role - Libbs; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); GlaxoSmithKline/Novartis (Inst); Roche/Genentech (Inst); Servier/Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche/Genentech
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Roche
Speakers' Bureau - Lilly; Novartis; Pfizer; Roche; Sandoz; Takeda; Theramex